|
1
|
Morin GB: The human telomere terminal
transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG
repeats. Cell. 59:521–529. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Greider CW and Blackburn EH: The telomere
terminal transferase of Tetrahymena is a ribonucleoprotein enzyme
with two kinds of primer specificity. Cell. 51:887–898. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greider CW and Blackburn EH:
Identification of a specific telomere terminal transferase activity
in Tetrahymena extracts. Cell. 43:405–413. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng J, Funk WD, Wang SS, et al: The RNA
component of human telomerase. Science. 269:1236–1241. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toshikuni N, Nouso K, Higashi T, et al:
Expression of telomerase-associated protein 1 and telomerase
reverse transcriptase in hepatocellular carcinoma. Br J Cancer.
82:833–837. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakayama J, Tahara H, Tahara E, et al:
Telomerase activation by hTRT in human normal fibroblasts and
hepatocellular carcinomas. Nat Genet. 18:65–68. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohta K, Kanamaru T, Morita Y, Hayashi Y,
Ito H and Yamamoto M: Telomerase activity in hepatocellular
carcinoma as a predictor of postoperative recurrence. J
Gastroenterol. 32:791–796. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakashio R, Kitamoto M, Tahara H,
Nakanishi T, Ide T and Kajiyama G: Significance of telomerase
activity in the diagnosis of small differentiated hepatocellular
carcinoma. Int J Cancer. 74:141–147. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kojima H, Yokosuka O, Imazeki F, Saisho H
and Omata M: Telomerase activity and telomere length in
hepatocellular carcinoma and chronic liver disease.
Gastroenterology. 112:493–500. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohta K, Kanamaru T, Yamamoto M and Saitoh
Y: Clinical significance of telomerase activity in hepatocellular
carcinoma. Kobe J Med Sci. 42:207–217. 1996.PubMed/NCBI
|
|
11
|
Ide T, Tahara H, Nakashio R, Kitamoto M,
Nakanishi T and Kajiyama G: Telomerase in hepatocellular
carcinogenesis. Hum Cell. 9:283–286. 1996.
|
|
12
|
Taga S, Osaki T, Ohgami A, Imoto H and
Yasumoto K: Prognostic impact of telomerase activity in non-small
cell lung cancers. Ann Surg. 230:715–720. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marchetti A, Bertacca G, Buttitta F, et
al: Telomerase activity as a prognostic indicator in stage I
non-small cell lung cancer. Clin Cancer Res. 5:2077–2081.
1999.PubMed/NCBI
|
|
14
|
Dome JS, Chung S, Bergemann T, et al: High
telomerase reverse transcriptase (hTERT) messenger RNA level
correlates with tumor recurrence in patients with favorable
histology Wilms’ tumor. Cancer Res. 59:4301–4307. 1999.PubMed/NCBI
|
|
15
|
Okusa Y, Shinomiya N, Ichikura T and
Mochizuki H: Correlation between telomerase activity and DNA ploidy
in gastric cancer. Oncology. 55:258–264. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bechter OE, Eisterer W, Pall G, Hilbe W,
Kühr T and Thaler J: Telomere length and telomerase activity
predict survival in patients with B cell chronic lymphocytic
leukemia. Cancer Res. 58:4918–4922. 1998.PubMed/NCBI
|
|
17
|
Langford LA, Piatyszek MA, Xu R, Schold SC
Jr, Wright WE and Shay JW: Telomerase activity in ordinary
meningiomas predicts poor outcome. Hum Pathol. 28:416–420. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hiyama E, Hiyama K, Ohtsu K, et al:
Telomerase activity in neuroblastoma: is it a prognostic indicator
of clinical behaviour? Eur J Cancer. 33:1932–1936. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clark GM, Osborne CK, Levitt D, Wu F and
Kim NW: Telomerase activity and survival of patients with
node-positive breast cancer. J Natl Cancer Inst. 89:1874–1881.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiyama E, Yokoyama T, Tatsumoto N, et al:
Telomerase activity in gastric cancer. Cancer Res. 55:3258–3262.
1995.PubMed/NCBI
|
|
21
|
Hiyama E, Hiyama K, Yokoyama T, Matsuura
Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels
with human neuroblastoma outcomes. Nat Med. 1:249–255. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saini N, Srinivasan R, Chawla Y, Sharma S,
Chakraborti A and Rajwanshi A: Telomerase activity, telomere length
and human telomerase reverse transcriptase expression in
hepatocellular carcinoma is independent of hepatitis virus status.
Liver Int. 29:1162–1170. 2009. View Article : Google Scholar
|
|
23
|
Suda T, Isokawa O, Aoyagi Y, et al:
Quantitation of telomerase activity in hepatocellular carcinoma: a
possible aid for a prediction of recurrent diseases in the remnant
liver. Hepatology. 27:402–406. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tatsuma T, Goto S, Kitano S, Lin YC, Lee
CM and Chen CL: Telomerase activity in peripheral blood for
diagnosis of hepatoma. J Gastroenterol Hepatol. 15:1064–1070. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kobayashi T, Kubota K, Takayama T and
Makuuchi M: Telomerase activity as a predictive marker for
recurrence of hepatocellular carcinoma after hepatectomy. Am J
Surg. 181:284–288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun B, Huang Q, Liu S, et al: Progressive
loss of malignant behavior in telomerase-negative tumorigenic
adrenocortical cells and restoration of tumorigenicity by human
telomerase reverse transcriptase. Cancer Res. 64:6144–6151. 2004.
View Article : Google Scholar
|
|
27
|
Brachner A, Sasgary S, Pirker C, et al:
Telomerase- and alternative telomere lengthening-independent
telomere stabilization in a metastasis-derived human non-small cell
lung cancer cell line: effect of ectopic hTERT. Cancer Res.
66:3584–3592. 2006. View Article : Google Scholar
|
|
28
|
Yu ST, Chen L, Wang HJ, Tang XD, Fang DC
and Yang SM: hTERT promotes the invasion of telomerase-negative
tumor cells in vitro. Int J Oncol. 35:329–336.
2009.PubMed/NCBI
|
|
29
|
Yao X, Wang X, Zhang S, Yan L and Zhu H:
Inhibitory effect of silencing hTERT gene on growth of human
squamous cell carcinoma xenograft in nude mice. Lin Chung Er Bi Yan
Hou Tou Jing Wai Ke Za Zhi. 25:939–943. 2011.(In Chinese).
|
|
30
|
George J, Banik NL and Ray SK: Knockdown
of hTERT and concurrent treatment with interferon-gamma inhibited
proliferation and invasion of human glioblastoma cell lines. Int J
Biochem Cell Biol. 42:1164–1173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato N, Maehara N, Mizumoto K, et al:
Telomerase activity of cultured human pancreatic carcinoma cell
lines correlates with their potential for migration and invasion.
Cancer. 91:496–504. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bagheri S, Nosrati M, Li S, et al: Genes
and pathways downstream of telomerase in melanoma metastasis. Proc
Natl Acad Sci USA. 103:11306–11311. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nart D, Yaman B, Yilmaz F, Zeytunlu M,
Karasu Z and Kiliç M: Expression of matrix metalloproteinase-9 in
predicting prognosis of hepatocellular carcinoma after liver
transplantation. Liver Transpl. 16:621–630. 2010.PubMed/NCBI
|
|
34
|
Arii S, Mise M, Harada T, et al:
Overexpression of matrix metalloproteinase 9 gene in hepatocellular
carcinoma with invasive potential. Hepatology. 24:316–322. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clark EA, Golub TR, Lander ES and Hynes
RO: Genomic analysis of metastasis reveals an essential role for
RhoC. Nature. 406:532–535. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ridley AJ: Rho GTPases and cell migration.
J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI
|
|
37
|
Van Aelst L and D’Souza-Schorey C: Rho
GTPases and signaling networks. Genes Dev. 11:2295–2322.
1997.PubMed/NCBI
|
|
38
|
Wang W, Yang LY, Huang GW, et al: Genomic
analysis reveals RhoC as a potential marker in hepatocellular
carcinoma with poor prognosis. Br J Cancer. 90:2349–2355.
2004.PubMed/NCBI
|
|
39
|
Wang W, Yang LY, Yang ZL, Huang GW and Lu
WQ: Expression and significance of RhoC gene in hepatocellular
carcinoma. World J Gastroenterol. 9:1950–1953. 2003.PubMed/NCBI
|
|
40
|
Okabe H, Satoh S, Kato T, et al:
Genome-wide analysis of gene expression in human hepatocellular
carcinomas using cDNA microarray: identification of genes involved
in viral carcinogenesis and tumor progression. Cancer Res.
61:2129–2137. 2001.
|
|
41
|
Kleer CG, Griffith KA, Sabel MS, et al:
RhoC-GTPase is a novel tissue biomarker associated with
biologically aggressive carcinomas of the breast. Breast Cancer Res
Treat. 93:101–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shikada Y, Yoshino I, Okamoto T, Fukuyama
S, Kameyama T and Maehara Y: Higher expression of RhoC is related
to invasiveness in non-small cell lung carcinoma. Clin Cancer Res.
9:5282–5286. 2003.PubMed/NCBI
|
|
43
|
Xue F, Takahara T, Yata Y, et al: Blockade
of Rho/Rho-associated coiled coil-forming kinase signaling can
prevent progression of hepatocellular carcinoma in matrix
metalloproteinase-dependent manner. Hepatol Res. 38:810–817. 2008.
View Article : Google Scholar
|
|
44
|
Iiizumi M, Bandyopadhyay S, Pai SK, et al:
RhoC promotes metastasis via activation of the Pyk2 pathway in
prostate cancer. Cancer Res. 68:7613–7620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Belair CD, Yeager TR, Lopez PM and
Reznikoff CA: Telomerase activity: a biomarker of cell
proliferation, not malignant transformation. Proc Natl Acad Sci
USA. 94:13677–13682. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Smith LL, Coller HA and Roberts JM:
Telomerase modulates expression of growth-controlling genes and
enhances cell proliferation. Nat Cell Biol. 5:474–479. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gronthos S, Chen S, Wang CY, Robey PG and
Shi S: Telomerase accelerates osteogenesis of bone marrow stromal
stem cells by upregulation of CBFA1, osterix, and osteocalcin. J
Bone Miner Res. 18:716–722. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xiang H, Wang J, Mao Y, Liu M, Reddy VN
and Li DW: Human telomerase accelerates growth of lens epithelial
cells through regulation of the genes mediating RB/E2F pathway.
Oncogene. 21:3784–3791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bednarek AK, Sahin A, Brenner AJ, Johnston
DA and Aldaz CM: Analysis of telomerase activity levels in breast
cancer: positive detection at the in situ breast carcinoma stage.
Clin Cancer Res. 3:11–16. 1997.PubMed/NCBI
|
